Background—The clinical effectiveness of implantable cardioverter-defibrillators (ICDs) in
older patients with heart failure has not been established, and older patients have been …

Background—Implantable cardioverter defibrillators (ICDs) are lifesaving devices for
patients with heart failure (HF) and reduced ejection fraction. However, utilization and …

Importance Improvement in left ventricular ejection fraction (EF) to> 35% occurs in many
patients with reduced EF at baseline. To our knowledge, whether implantable cardioverter …

Objectives: To investigate the generalizability of the reduction in mortality posed by
implantable cardioverter-defibrillators, we examined the effectiveness of defibrillators as …

Objectives: The aim of this study was to determine if the benefit of implantable cardioverter-
defibrillators (ICDs) is modulated by medical comorbidity. Background: Primary prevention …

Objectives: This study sought to assess the impact of baseline heart failure (HF) burden on
survival with primary implantable cardioverter-defibrillator (ICD) among Medicare recipients …

BACKGROUND: Although implantable cardioverter defibrillators (ICDs) are increasingly
used in advanced (class III/IV) heart failure, their benefits may be limited by death from pump …

The aim of this study was to investigate the association between implantable cardioverter-
defibrillator (ICD) status at the time of hospitalization for worsening heart failure (HF) with …

BACKGROUND: Clinical guidelines recommend implantable cardioverter-defibrillators
(ICDs) for selected patients with chronic left ventricular dysfunction (LVD) to improve …

Background Many current predictors of mortality in heart failure (HF) were evaluated before
the use of implantable cardioverter defibrillators (ICDs). We conducted a meta-analysis to …